Pharmaceutical supply chain networks with outsourcing under price and quality competition

International Transactions in Operational Research

Volumn 20, Issue 6, 2013, Pages 859-888

  Nagurney, Anna ^a,b   Li, Dong ^a   Nagurney, Ladimer S ^c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF HARTFORD   (United States)

Author keywords

Competition; Dynamical systems; Game theory; Healthcare; Outsourcing; Pharmaceutical products; Quality; Supply chain networks; Supply chains; Variational inequalities

Indexed keywords

ASSOCIATED FUNCTIONS; EQUILIBRIUM CONDITIONS; MAKE-OR-BUY DECISIONS; PHARMACEUTICAL FIRMS; PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL SUPPLY CHAINS; SUPPLY CHAIN NETWORK; VARIATIONAL INEQUALITIES;

COMPETITION; CONTRACTORS; COSTS; DYNAMICAL SYSTEMS; GAME THEORY; HEALTH CARE; IMAGE QUALITY; INDUSTRY; MANUFACTURE; OPTIMIZATION; OUTSOURCING; SUPPLY CHAINS; VARIATIONAL TECHNIQUES;

DRUG PRODUCTS;

EID: 84885474026     PISSN: 09696016     EISSN: 14753995     Source Type: Journal    
DOI: 10.1111/itor.12031     Document Type: Article

References (85)

1. Akerlof, G.A., 1970. The market for lemons: quality uncertainty and the market mechanism. Quarterly Journal of Economics 84, 3, 488-500.
2. Amaral, J., Billington, C., Tsay, A., 2006. Safeguarding the promise of production outsourcing. Interfaces 36, 3, 220-233.
3. ASQC (American Society for Quality Control), 1971. Quality Costs, What and How (2nd edn). ASQC Quality Press, Milwaukee, WI.
4. Aubert, B.A., Rivard, S., Patry, M., 1996. A transaction costs approach to outsourcing: some empirical evidence. Information and Management 30, 51-64.
5. Austin, W., Hills, M., Lim, E., 2003. Outsourcing of R&D: how worried should we be? National Academies, Government University Industry Research Roundtable, December.
6. Balakrishnan, K., Mohan, U., Seshadri, S., 2008. Outsourcing of front-end business processes: quality, information, and customer contact. Journal of Operations Management 26, 6, 288-302.
7. Bazaraa, M.S., Sherali, H.D., Shetty, C.M., 1993. Nonlinear Programming: Theory and Algorithms. John Wiley & Sons, New York.
8. Bertrand, J., 1883. Théorie mathématique de la richesse sociale. Journal des Savants, September, 499-508.
9. Bogdanich, W., Hooker, J., 2007. From China to Panama, a trail of poisoned medicine. The New York Times, May 1, 6, 24, and 25.
10. Bristol-Myers Squibb, 2005. Bristol-Myers Squibb company signs manufacturing agreement with Celltrion. Available at http://www.thefreelibrary.com/Bristol-Myers+Squibb+Company+Signs+Manufacturing+Agreement+With...-a0133423982 (accessed 11 January 2013).
11. BS (British Standards) 6143: Part 2, 1990. Guide to Determination and Use of Quality-Related Costs. British Standards Institution, London.
12. Campanella, J., 1990. Principles of Quality Costs (2nd edn). ASQC Quality Press, Milwaukee, WI.
13. Chase, R.B., Jacobs, F.R., Aquilano, N.J., 2004. Operations Management for Competitive Advantage (10th edn). McGraw-Hill, Boston, MA.
14. Coase, R.H., 1937. The nature of the firm. Economica 4, 386-405.
15. Cockburn, I.M., 2004. The changing structure of the pharmaceutical industry. Health Affairs 23, 1, 10-22.
16. Cournot, A.A., 1838. Researches into the Mathematical Principles of the Theory of Wealth (English translation). Macmillan, London, 1897.
17. Crosby, P.B., 1979. Quality is Free. McGraw-Hill, New York.
18. Cruz, J.M., 2008. Dynamics of supply chain networks with corporate social responsibility through integrated environmental decision-making. European Journal of Operational Research 184, 1005-1031.
19. Dafermos, S.C., Sparrow, F.T., 1969. The traffic assignment problem for a general network. Journal of Research of the National Bureau of Standards 73B, 91-118.
20. Dong, J., Zhang, D., Nagurney, A., 2004. A supply chain network equilibrium model with random demands. European Journal of Operational Research 156, 194-212.
21. Dong, J., Zhang, D., Yan, H., Nagurney, A., 2005. Multitiered supply chain networks: multicriteria decision-making under uncertainty. Annals of Operations Research 135, 155-178.
22. Dupuis, P., Nagurney, A., 1993. Dynamical systems and variational inequalities. Annals of Operations Research 44, 9-42.
23. Economy in Crisis, 2010. U.S. Pharmaceutical outsourcing threat. Available at http://economyincrisis.org/content/outsourcing-americas-medicine (accessed 8 September 2011).
24. Enyinda, C.I., Briggs, C., Bachkar, K., 2009. Managing risk in pharmaceutical global supply chain outsourcing: applying analytic hierarchy process model. Paper Presented at the American Society of Business and Behavioral Sciences, February 19-22, Las Vegas, Nevada.
25. European Commission Health and Consumers Directorate-General, 2010. The Rules Governing Medicinal Products in the European Union, Vol. 4, Chapter 7.
26. FDA, 2002. FDA's general CGMP regulations for human drugs. In: Codes of Federal Regulations, parts 210 and 211.
27. Feigenbaum, A.V., 1991. Total Quality Control (3rd edn). McGraw-Hill, New York.
28. Franceschini, F., Galetto, M., Pignatelli, A., Varetto, M., 2003. Outsourcing: guidelines for a structured approach. Benchmarking: An International Journal 10, 246-260.
29. Gabay, D., Moulin, H., 1980. On the uniqueness and stability of Nash equilibria in noncooperative games. In Bensoussan, A., Kleindorfer, P., Tapiero, C.S. (eds) Applied Stochastic Control in Econometrics and Management Science. North-Holland, Amsterdam, pp. 271-294.
30. Gan, D., Litvinov, E., 2003. Energy and reserve market designs with explicit consideration to lost opportunity costs. IEEE Transactions on Power Systems 18, 1, 53-59.
31. Garofolo, W., Garofolo, F., 2010. Global outsourcing. Bioanalysis 2, 149-152.
32. Grabowski, H., Vernon, J., 1990. A new look at the returns and risks to pharmaceutical R&D. Management Science 36, 7, 804-821.
33. Gray, J.V., Roth, A.V., Tomlin, B., 2008. Quality risk in contract manufacturing: evidence from the U.S. drug industry. Working paper.
34. Harrington, H.J., 1987. Poor-Quality Cost. ASQC Quality Press, Milwaukee, WI.
35. Hayes, R., Pisano, G., Upton, D., Wheelwright, S., 2005. Operations, Strategy, and Technology: Pursuing the Competitive Edge. John Wiley & Sons, New York.
36. Helm, K.A., 2006. Outsourcing the fire of genius: the effects of patent infringement jurisprudence on pharmaceutical drug development. Fordham Intellectual Property Media & Entertainment Law Journal 17, 153-206.
37. Heshmati, A., 2003. Productivity growth, efficiency and outsourcing in manufacturing and service industries. Journal of Economic Surveys 17, 1, 79-112.
38. Higgins, M.J., Rodriguez, D., 2006. The outsourcing of R&D through acquisitions in the pharmaceutical industry. Journal of Financial Economics 80, 351-383.
39. John, S., 2006. Leadership and strategic change in outsourcing core competencies: lessons from the pharmaceutical industry. Human Systems Management 25, 2, 35-143.
40. Juran, J.M., Gryna, F.M., 1988. Quality Control Handbook (4th edn). McGraw-Hill, New York.
41. Juran, J.M., Gryna, F.M., 1993. Quality Planning and Analysis, McGraw-Hill, New York.
42. Kaya, O., 2011. Outsourcing vs. in-house production: a comparison of supply chain contracts with effort dependent demand. Omega 39, 168-178.
43. Kaya, M., Özer, Ö., 2009. Quality risk in outsourcing: noncontractible product quality and private quality cost information. Naval Research Logistics 56, 669-685.
44. Klopack, T.G, 2000. Strategic outsourcing: balancing the risks and the benefits. Drug Discovery Today 54, 157-160.
45. Leland, H.E., 1979. Quacks, lemons, and licensing: a theory of minimum quality standards. Journal of Political Economy 87, 6, 1328-1346.
46. Liu, Z., Nagurney, A., 2011a. Supply chain networks with global outsourcing and quick-response production under demand and cost uncertainty. To appear in Annals of Operations Research. DOI 10.1007/s10479-011-1006-0
47. Liu, Z., Nagurney, A., 2011b. Supply chain outsourcing under exchange rate risk and competition. Omega 39, 539-549.
48. Mankiw, G.N., 2011. Principles of Microeconomics (6th edn). South-Western, Cengage Learning, Mason, OH.
49. Masoumi, A.H., Yu, M., Nagurney, A., 2012. A supply chain generalized network oligopoly model for pharmaceuticals under brand differentiation and perishability. Transportation Research E 48, 762-780.
50. Nagurney, A., 1999. Network Economics: A Variational Inequality Approach. Kluwer Academic Publishers, Dordrecht.
51. Nagurney, A., 2006. Supply Chain Network Economics: Dynamics of Prices, Flows, and Profits. Edward Elgar Publishing, Cheltenham.
52. Nagurney, A., 2010. Formulation and analysis of horizontal mergers among oligopolistic firms with insights into the merger paradox: a supply chain network perspective. Computational Management Science 7, 377-410.
53. Nagurney, A., Dong, J., Zhang, D., 2002. A supply chain network equilibrium model. Transportation Research E 38, 5, 251-303.
54. Nagurney, A., Dupuis, P., Zhang, D., 1994. A dynamical systems approach for network oligopolies and variational inequalities. Annals of Regional Science 28, 263-283.
55. Nagurney, A., Ke, K., Cruz, J., Hancock, K., Southworth, F., 2002. Dynamics of supply chains: a multitiered (logistical/informational/financial) network perspective. Environment & Planning B 29, 795-818.
56. Nagurney, A., Li, D., 2012. A dynamic network oligopoly model with transportation costs, product differentiation, and quality competition. To appear in Computational Economics. DOI 10.1007/s10614-013-9387-6
57. Nagurney, A., Takayama, T., Zhang, D., 1995. Massively parallel computation of spatial price equilibrium problems as dynamical systems. Journal of Economic Dynamics and Control 18, 3-37.
58. Nagurney, A., Yu, M., 2011. Fashion supply chain management through cost and time minimization from a network perspective. In Choi, T.M. (ed.) Fashion Supply Chain Management: Industry and Business Analysis. IGI Global, Hershey, PA, pp. 1-20.
59. Nagurney, A., Yu, M., Qiang, Q., 2011. Supply chain network design for critical needs with outsourcing. Papers in Regional Science 90, 123-142.
60. Nagurney, A., Zhang, D., 1996. Projected Dynamical Systems and Variational Inequalities with Applications. Kluwer Academic Publishers, Boston, MA.
61. Nagurney, A., Zhang, D., 1997. Projected dynamical systems in the formulation, stability analysis, and computation of fixed-demand traffic network equilibria. Transportation Science 31, 2, 147-158.
62. Nash, J.F., 1950. Equilibrium points in n-person games. Proceedings of the National Academy of Sciences, USA 36, 48-49.
63. Nash, J.F., 1951. Noncooperative games. Annals of Mathematics 54, 286-298.
64. New Oxford American Dictionary, 2010. 3rd edition. Stevenson, A., Lindberg, C.A. (eds), Oxford University Press, Oxford.
65. Olson, D., Wu, D., 2011. Risk management models for supply chain: a scenario analysis of outsourcing to China. Supply Chain Management: An International Journal 16, 6, 401-408.
66. Palmer, S., Raftery, J., 1999. Economics notes: opportunity cost. British Medical Journal 318, 7197, 1551-1552.
67. Payne, J.W., Bettman, J.R., Luce, M.F., 1996. When time is money: decision behavior under opportunity-cost time pressure. Organizational Behavior and Human Decision Processes 66, 2, 131-152.
68. Payne, P., 2008. Is pharma's supply chain safe? Pharmaceutical Technology Europe 20, 7, 15-16.
69. Picot, A., Reichwald, R., Wigand, R.T., 1996. Die Grenzenlose Unternehmung: Information, Organisation und Management (2nd edn). Gabler, Wiesbaden.
70. Plunkett, J.J., Dale, B.G., 1988. Quality costs: a critique of some "economic cost of quality" models. International Journal of Production Research 26, 1713-1726.
71. Porter, L.J., Rayner, P., 1992. Quality costing for total quality management. International Journal of Production Economics 27, 69-81.
72. Porteus, E.L., 1986. Optimal lot sizing, process quality improvement and setup cost reduction. Operations Research 34, 1, 137-144.
73. Purtell, D., 2010. A risk-based remedy for pharma supply chain security concerns. BSI Group America Inc., Reston, VA.
74. Qiang, Q., Nagurney, A., 2012. A bi-criteria indicator to assess supply chain network performance for critical needs under capacity and demand disruptions. Transportation Research A 46(5), 801-812.
75. Rapley, C.W., Prickett, T.W., and Elliot, M.P., 1999. Quality costing: a study of manufacturing organizations. Part 1: case studies and survey. Total Quality Management 10, 1, 85-93.
76. Sandoval-Chavez, D.A., Beruvides, M.G., 1998. Using opportunity costs to determine the cost of quality: a case study in a continuous-process industry. Engineering Economist 43, 107-124.
77. Schneiderman, A.M., 1986. Optimum quality costs and zero defects. Quality Progress, November, 28-31.
78. Shank, J.K., Govindarajan, V., 1994. Measuring the cost of quality: a strategic cost management perspective. Cost Management, Summer, 5-17.
79. Sink, H.L., Langley Jr, J.C., 1997. A managerial framework for the acquisition of third party logistics services. Journal of Business Logistics 18, 2, 163-189.
80. The New York Times, 2011. Deal in place for inspecting foreign drugs. Available at http://www.nytimes.com/2011/08/13/science/13drug.html (accessed 11 January 2013).
81. U.S. Department of Health and Human Services, FDA (Food and Drug Administration), CDER (Center for Drug Evaluation and Research), CBER (Center for Biologics Evaluation and Research), 2009. Guidance for Industry: Q10 Pharmaceutical Quality System.
82. Wheelwright, S.M., Downey, W., 2008. Biopharmaceutical contract manufacturing: recent industry growth. Pharmaceutical Outsourcing 9, 3, 16-21.
83. Yu, M., Nagurney, A., 2013. Competitive food supply chain networks with application to fresh produce. European Journal of Operational Research 224, 2, 273-282.
84. Zhang, D., Nagurney, A., 1995. On the stability of projected dynamical systems. Journal of Optimization Theory and Its Applications 85, 97-124.
85. Zhou, Y., 2007. Opportunities in biopharmaceutical outsourcing to China. BioProcess International 5, 1, 16-23.